People / Staff

Marta Giralt Oms

Search publications

Publications

  • Domingo P, Lamarca MK, Gallego-Escuredo JM, Torres F, Domingo JC, Villarroya-Terrade J, Gutierrez Mdel M, Mateo MG, Vidal F, Villarroya-Gombau F and Giralt M.

    Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 70(6): 1825-1832. Number of citations: 11

    [doi:10.1093/jac/dkv027]

  • Guzmán-Ruiz R, Ortega F, Rodríguez A, Vázquez-Martínez R, Díaz-Ruiz A, Garcia-Navarro S, Giralt M, Garcia-Rios A, Cobo-Padilla D, Tinahones FJ, López-Miranda J, Villarroya-Gombau F, Frühbeck G, Fernández-Real JM and Malagón MM.

    Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in ß-cells.

    INTERNATIONAL JOURNAL OF OBESITY . 38(12): 1545-1554. Number of citations: 76

    [doi:10.1038/ijo.2014.36]

  • Villarroya-Terrade J, Flachs P, Redondo-Angulo I, Giralt M, Medrikova D, Villarroya-Gombau F, Kopecky J and Planavila A.

    Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids.

    Lipids . 49(11): 1081-1089. Number of citations: 20

    [doi:10.1007/s11745-014-3948-x]

  • Domingo P, Gutierrez Mdel M, Gallego-Escuredo JM, Torres F, Mateo MG, Villarroya-Terrade J, Lamarca K, Domingo JC, Vidal F, Villarroya-Gombau F and Giralt M.

    A 48-week study of fat molecular alterations in HIV naive patients starting tenofovir/emtricitabine with lopinavir/ritonavir or efavirenz.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 66(5): 457-465. Number of citations: 13

    [doi:10.1097/QAI.0000000000000205]

  • Hondares E, Gallego-Escuredo JM, Flachs P, Frontini A, Cereijo R, Goday A, Perugini J, Kopecky P, Giralt M, Cinti S, Kopecky J and Villarroya-Gombau F.

    Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.

    METABOLISM-CLINICAL AND EXPERIMENTAL . 63(3): 312-317. Number of citations: 73

    [doi:10.1016/j.metabol.2013.11.014]

  • Gallego-Escuredo JM, Villarroya-Terrade J, Domingo P, Targarona EM, Alegre M, Domingo JC, Villarroya-Gombau F and Giralt M.

    Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 64(2): 142-148. Number of citations: 27

    [doi:10.1097/QAI.0b013e31829bdb67]

  • Gallego-Escuredo JM, Domingo P, Fontdevila J, Villarroya-Terrade J, Domingo JC, Martinez E, Giralt M and Villarroya-Gombau F.

    Hypertrophied facial fat in an HIV-1-infected patient after autologous transplantation from 'buffalo hump' retains a partial brown-fat-like molecular signature.

    ANTIVIRAL THERAPY . 18(4): 635-639. Number of citations: 3

    [doi:10.3851/IMP2528]

  • Planavila A, Dominguez E, Navarro M, Vinciguerra M, Iglesias R, Giralt M, Lope-Piedrafita S, Ruberte J and Villarroya-Gombau F.

    Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: a role for Sirt1-Mef2 in adult heart.

    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY . 53(4): 521-531. Number of citations: 75

    [doi:10.1016/j.yjmcc.2012.07.019]

  • Díaz-Delfín J, Domingo P, Mateo MG, Gutierrez Mdel M, Domingo JC, Giralt M and Villarroya-Gombau F.

    Effects of rilpivirine on human adipocyte differentiation, gene expression, and release of adipokines and cytokines.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 56(6): 3369-3375. Number of citations: 28

    [doi:10.1128/AAC.00104-12]

  • Armengol J, Villena JA, Hondares E, Carmona MC, Sul HS, Iglesias R, Giralt M and Villarroya-Gombau F.

    Pref-1 in brown adipose tissue: specific involvement in brown adipocyte differentiation and regulatory role of C/EBPd.

    BIOCHEMICAL JOURNAL . 443(3): 799-810. Number of citations: 22

    [doi:10.1042/BJ20111714]